Rights and permissions
About this article
Cite this article
Adjuvant trastuzumab promising but costly for breast cancer. Pharmacoecon. Outcomes News 500, 3 (2006). https://doi.org/10.2165/00151234-200605000-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605000-00004